Skip to content
University of Bristol logo

The LEADER-PAD Study

Low dose colchicine in patients with peripheral artery disease to address residual vascular risk: A randomised trial.

  • Welcome
    • Research Sites
    • Acknowledgements
    • Meet The Study Team
    • Contact
  • Taking Part In LEADER-PAD
  • Site Information
    • NIHR Associate PI Scheme
    • Study Documentation
    • FAQs
    • News

INVESTIGATIONAL MEDICINAL PRODUCT DOCUMENTS

Colchicine – UK version Colchicine Tiofarma 0.5 mg tabletten-smpc

Investigators’ Brochure IBTiofarma_FinalV1.0_20240527

LEADER-PAD Local Pharmacy Manual v1.3

LEADERPAD_IMPD Colchicine 0.5 mg and Placebo tablets_v1.0

Eramol MIA(IMP) 49160 v11

Tiofarma Manufacturing authorisation_updated May 2024

Tiofarma GMP compliance certificate

MIA 6906 F (Tjoapack Netherlands, Etten-Leur)

LEADER-PAD Baseline (active run-in) Dispensing Log v1.0

LEADER-PAD Baseline (active run-in) Prescription Form V1.0

LEADER-PAD Trial IMP (post-randomisation) Prescription Form v1.0

LEADER-PAD Trial IMP (post randomisation) Dispensing Log v1.0

GMP Compliance Certificate

Menu

  • Welcome
    • Research Sites
    • Acknowledgements
    • Meet The Study Team
    • Contact
  • Taking Part In LEADER-PAD
  • Site Information
    • NIHR Associate PI Scheme
    • Study Documentation
    • FAQs
    • News

Menu

  • Welcome
    • Research Sites
    • Acknowledgements
    • Meet The Study Team
    • Contact
  • Taking Part In LEADER-PAD
  • Site Information
    • NIHR Associate PI Scheme
    • Study Documentation
    • FAQs
    • News
© 2025 University of Bristol | Terms of use